Isosceles Pharmaceuticals, Inc.

CIK: 1949237NVIncorporated: 2019-04-12

Current Offering

$20,000
Target Amount
$5,000,000
Maximum Amount
2023-10-02
Deadline

Security Details

Type: Common Stock
Price per share: $2.05
Shares offered: 9,756+

Offering Costs

Cash commission: 7%
The Intermediary will receive a commission equal to seven percent (7%) of the amount raised in the offering.
Equity compensation: 7%
The Intermediary will receive a number of shares of common stock of the issuer that is equal to seven percent (7%) of the total number of shares of common stock sold by the issuer in the offering.

Financial Reports

Offering via Equifund Crowd Funding Portal Inc.

Offering History

As of 2022-10-03
Raising $20,000 -$5,000,000 via 9,756+ shares of common Stock at $2.05 per share
Deadline: 2023-10-02
Filing date2022-10-03
Current employees10
Act received most recent fiscal year$0.00
Act received prior fiscal year$0.00
Cash equi most recent fiscal year$212,834
Cash equi prior fiscal year$198,240
Cost goods sold most recent fiscal year$0.00
Cost goods sold prior fiscal year$0.00
Long term debt most recent fiscal year$120,000
Long term debt prior fiscal year$0.00
Net income most recent fiscal year$879,786
Net income prior fiscal year$891,911
Revenue most recent fiscal year$0.00
Revenue prior fiscal year$0.00
Short term debt most recent fiscal year$0.00
Short term debt prior fiscal year$0.00
Tax paid most recent fiscal year$0.00
Tax paid prior fiscal year$0.00
Total asset most recent fiscal year$212,834
Total asset prior fiscal year$198,240

Company Information

Corporation
NV
2019-04-12

Latest Metrics

Employees10
Total Assets$212,834
Cash on Hand$212,834
Revenues$0.00
Net Income$879,786

Crowdfunding Portals

This company is raising funds through this portal